- Price
- Options
- Balance Sheet
- Cash Flow
- Income Statement
- Historical Prices

- Scuttles
- Sentiment
- Social Data

- News/Articles
- Video

Editas Medicine Inc - EDIT

Realtime Prices, Sentiment, Tweets, Scuttles, News and discussions on Editas Medicine Inc. Editas Medicine, Inc., formerly Gengine, Inc., is a genome editing company. The Company is engaged in treating patients with genetically defined diseases by correcting their disease-causing genes. The Company is developing a genome editing platform based on CRISPR/Cas9 technology. The Company's CRISPR/Cas9 uses a protein-ribonucleic acid (RNA) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a particular deoxyribonucleic acid (DNA) sequence. The Company's platform consists of four interrelated components: nuclease engineering, delivery, control and specificity, and directed editing. The Company's research programs address genetic, infectious, and oncologic diseases of the liver, lung, blood, eye, and muscle. The Company's advanced program is designed to address a specific genetic form of retinal degeneration called Leber Congenital Amaurosis type 10 (LCA10).
Followers: 14   |   Latest: ()   |  After hours: () Add to Watchlist


Loading now... loading......

More Scuttles »

Powered by Headlne

Loading now... loading......

Loading now... loading......

More Headlnes »

For a limited time get your FREE Stock Traders Daily report on EDIT. Get it now.

Bullish/Bearish Indicator

Select your view on EDIT


0% bullish

0% bearish

Sentiment figures will update once enough data is captured

Who is Bullish & Who is Bearish?

Learn more about our Sentiment Indicators

Advance Charting on EDIT »


Loading now... loading......

Block Trades

Loading now... loading......